ARROWHEAD PHARMACEUTICALS, INC. Business Segments Arrowhead Pharmaceuticals, Inc.
Equities
ARWR
US04280A1007
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.08 USD | +4.20% |
|
-5.42% | -31.32% |
| 09-10 | Arrowhead Pharmaceuticals' Plozasiran Receives FDA Breakthrough Therapy Designation | MT |
| 09-10 | Arrowhead Pharmaceuticals Gets FDA Breakthrough Designation for Plozasiran | DJ |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: September | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Nanotechnology | 169M | 87.99M | 138M | 243M | 241M | |||||
Total Assets | 350M | 523M | 710M | 692M | 766M | |||||
Interest Expense | -42.23K | - | - | - | -18.33M | |||||
Income Tax Expense | 174K | 2.4K | 2K | 3.78M | 2.78M | |||||
CAPEX | -12M | -11.95M | -23.57M | -52.78M | -177M | |||||
EBT | 68.15M | -84.55M | -141M | -173M | -206M | |||||
D&A | 4.44M | 5.94M | 8.27M | 10.42M | 12.49M | |||||
Operating Income | 61.19M | -93.16M | -149M | -179M | -205M | |||||
Net Income | 67.97M | -84.55M | -141M | -176M | -205M |
Geographical Revenue Distribution History
| Fiscal Period: September | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 169M | 87.99M | 138M | 243M | 241M | |||||
Total Assets | 350M | 523M | 710M | 692M | 766M | |||||
Interest Expense | -42.23K | - | - | - | -18.33M | |||||
Income Tax Expense | 174K | 2.4K | 2K | 3.78M | 2.78M | |||||
D&A | 4.44M | 5.94M | 8.27M | 10.42M | 12.49M | |||||
CAPEX | -12M | -11.95M | -23.57M | -52.78M | -177M | |||||
Net Income | 67.97M | -84.55M | -141M | -176M | -205M | |||||
EBT | 68.15M | -84.55M | -141M | -173M | -206M | |||||
Operating Income | 61.19M | -93.16M | -149M | -179M | -205M |
- Stock Market
- Equities
- ARWR Stock
- Financials Arrowhead Pharmaceuticals, Inc.
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition